These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10746825)

  • 1. Biphasic changes in nitric oxide generation in hemodialyzed patients with end-stage renal disease treated with recombinant human erythropoietin.
    Kang ES; Wang YB; Cardenas R; Tevlin MT; Mishra S; Acchiardo SR
    Am J Med Sci; 2000 Mar; 319(3):149-57. PubMed ID: 10746825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.
    Kang ES; Miles DE; Tevlin MT; Cates TB; Acchiardo SR
    Am J Med Sci; 2001 Feb; 321(2):113-23. PubMed ID: 11217813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients.
    Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of serum apelin-13 is positively correlated with ADMA in patients on maintenance hemodialysis.
    Zhang DL; Liao H; Wei YY; Zhang Y; Zhang QD; Wang ZG
    Clin Nephrol; 2009 Apr; 71(4):405-12. PubMed ID: 19356373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotension during hemodialysis: role for nitric oxide.
    Kang ES; Acchiardo SR; Wang YB; Tevlin MT; Hughes T; Cardoso S
    Am J Med Sci; 1997 Mar; 313(3):138-46. PubMed ID: 9075430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin treatment of anemia in renal transplant patients.
    Lezaic V; Djukanovic L; Pavlovic-Kentera V
    Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients.
    Jungers P; Choukroun G; Oualim Z; Robino C; Nguyen AT; Man NK
    Nephrol Dial Transplant; 2001 Feb; 16(2):307-12. PubMed ID: 11158405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
    Carlini R; Obialo CI; Rothstein M
    Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy.
    Movilli E; Pertica N; Camerini C; Cancarini GC; Brunori G; Scolari F; Maiorca R
    Am J Kidney Dis; 2002 Apr; 39(4):850-3. PubMed ID: 11920353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased nitric oxide production in hypotensive hemodialysis patients.
    Lin SH; Chu P; Yu FC; Diang LK; Lin YF
    ASAIO J; 1996; 42(5):M895-9. PubMed ID: 8945014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M; Alonso A; Avilla JM; Espinosa L
    Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients.
    Miyashita K; Tojo A; Kimura K; Goto A; Omata M; Nishiyama K; Fujita T
    Hypertens Res; 2004 Feb; 27(2):79-84. PubMed ID: 15005270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
    House AA; Pham B; Pagé DE
    Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
    Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
    Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of recombinant human erythropoietin in predialysis patients.
    Portolés J; Torralbo A; Martin P; Rodrigo J; Herrero JA; Barrientos A
    Am J Kidney Dis; 1997 Apr; 29(4):541-8. PubMed ID: 9100042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis.
    Stefanidis I; Mertens PR; Wurth P; Bach R; Makropoulos W; Mann H; Heintz B
    Int J Artif Organs; 2001 Jun; 24(6):367-73. PubMed ID: 11482502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period.
    Kang ES; Tevlin MT; Wang YB; Chiang TM; Cardenas R; Myers LK; Acchiardo SR
    Am J Med Sci; 1999 Jan; 317(1):9-21. PubMed ID: 9892267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of recombinant human erythropoietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study).
    Akizawa T; Saito A; Gejyo F; Suzuki M; Nishizawa Y; Tomino Y; Tsubakihara Y; Akiba T; Hirakata H; Watanabe Y; Kawanishi H; Bessho M; Udagawa Y; Aoki K; Uemura Y; Ohashi Y;
    Ther Apher Dial; 2014 Apr; 18(2):140-8. PubMed ID: 24720404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy.
    Małyszko J; Zbroch E; Wołczyński S; Małyszko JS; Hryszko T; Myśliwiec M
    Am J Nephrol; 2000; 20(3):180-6. PubMed ID: 10878398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.